Shea, Michael <br/><br/>
Regulatory Watch: Impact of breakthrough therapy designation on cancer drug development.  [electronic resource] 

 -  Nature reviews. Drug discovery  Mar 2016 
 - 152 p.  digital 
<br/><br/> Publication Type: News 
<br/><br/><label>ISSN: </label>1474-1784 
<br/><br/><label>Standard No.: </label>10.1038/nrd.2016.19  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Antineoplastic Agents--therapeutic use<br/>Clinical Trials as Topic--legislation & jurisprudence<br/>Drug Discovery--legislation & jurisprudence<br/>Humans<br/>Neoplasms--drug therapy<br/>United States<br/>United States Food and Drug Administration--legislation & jurisprudence